
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (8) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (22) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (11) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (48) Apply Medical devices/IVDs filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- Remove OTC medicines filter OTC medicines (31)
- Prescription medicines (25) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (37) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (6) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Kunzea ambigua: proposed advisory statements for medicines
Closed on 18 January 2013
Azelastine: proposed advisory statements for medicines
Closed on 7 December 2012
Famciclovir: proposed advisory statements for medicines
Closed on 7 December 2012
Loratadine and desloratadine: proposed advisory statements for medicines
Closed on 7 December 2012
Over-the-counter (OTC) medicines business process reform
Closed on 7 November 2012
Fexofenadine and loperamide: proposed advisory statements for medicines
Closed on 4 June 2012
Proposed advisory statements for medicines: Cough and cold medicines for use in children
Closed on 22 February 2012
Australian regulatory guidelines for over-the-counter medicines (ARGOM) - Stage 1
Closed on 10 February 2012
Proposed changes to the sunscreens section of the ARGOM
Closed on 18 June 2010